Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

ROLE of Clinical Research Associate

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 25
At a glance
Powered by AI
The key roles and responsibilities of a sponsor, investigator, CRA and clinical trial process were discussed.

A sponsor is responsible for initiating, managing and financing clinical trials. Key sponsor responsibilities include quality assurance, trial design, selection of investigators, safety monitoring and providing study reports.

An investigator is responsible for proper conduct of a clinical trial at their site. Key investigator responsibilities include qualifications, permitting monitoring, having adequate resources and complying with GCP guidelines.

Responsibilities of Sponsor,

Investigator and Monitor

1
Learning Objective

Roles and Responsibilities of the

 Sponsor

 Investigator

 Clinical research associate

 Clinical research coordinator

2
Key Players in a Clinical Trial

CRA

Investigator Patient

Clinical
Trial

Regulatory Ethics
Authorities Committee

Sponsor
3
Sponsor

 Who is Sponsor?

An individual, company, institution, or organisation


which takes responsibility for the

 Initiation

 Management

 Financing of a clinical trial.

ICH E6, 1.53

4
Sponsor’s Responsibilities

 Quality Assurance & Quality Control


 To ensure that trials are conducted & data are generated,
documented & reported in compliance with the protocol,
GCP & applicable regulatory requirements.
 To ensure direct access to trial related data by the
sponsor or inspector (auditor).

 Medical Expertise
 Should designate qualified medical personnel to advise
trial related medical questions

5
Sponsor’s Responsibilities…cont’d

 Trial Design
 Trial management, data handling, record keeping
 Investigator selection
 Compensation to Subjects & Investigators
 Provide insurance or indemnity to subjects or investigator /
institution
 Financing
 Financial written agreement between sponsor & investigator
 Application to regulatory body for permission to conduct the
trial

6
Sponsor’s Responsibilities…cont’d

 Information on investigational product

 Ensure that sufficient safety & efficacy data from non

clinical studies are available to support human exposure

 Manufacturing & packaging of IP


 Ensure that IP is manufactured as per applicable GMP and
appropriately coded, labeled & packaged

7
Sponsor’s Responsibilities…cont’d

 Safety information
 Responsible for ongoing safety evaluation of IP

 Monitoring & Audit


 To ensure that conduct of trial is in accordance with
approved protocol

 Clinical Study Reports


 To prepare and provide reports to regulatory authorities

8
Investigator
 Who is Investigator?

A person responsible for the conduct of the clinical


trial at a trial site.

If a trial is conducted by a team of individuals at a


trial site, the investigator is the responsible leader
of the team and may be called as Principal
Investigator.

9
Investigator’s Responsibilities

 Qualifications and Agreements


 Should be qualified by education, training and experience
to assume responsibility for the proper conduct of trial
 Permit monitoring and auditing by sponsor and inspection
by regulatory authority
 Adequate Resources
 Should be able to demonstrate a potential for recruiting
the required number of suitable subjects
 Sufficient time, adequate number of qualified staff and
adequate facilities

10
Investigator’s Responsibilities…cont’d

 Medical Care of Trial Subjects


 Responsible for all trial related medical decisions and
ensure that adequate medical care is provided to a
subject for any AE related to trial
 Communication with IRB/IEC
 Written and dated approval from IRB/IEC before
initiating the trial
 Keep IRB/IEC apprise of all deviations, SAEs & progress
during the study

11
Investigator’s Responsibilities…cont’d

 Compliance with Protocol


 Conduct the study according to protocol
 No deviation from protocol without agreement by the
sponsor & prior review/approval from IRB/IEC

 Investigational Product
 IP accountability & maintenance of records of the
product’s delivery to the site, inventory at site, use by the
subject, return to sponsor or destruction.
 Storage & use of IP according to protocol

12
Investigator’s Responsibilities…cont’d

 Informed Consent of Study Subjects


 Provide IRB/IEC approved written informed consent form
to subject
 Should not coerce or unduly influence subjects to
participate
 Language of informed consent form should be
nontechnical and understandable to the subject
 Subject should be given ample time and opportunity to
ask questions
 Subject should sign and personally date informed consent
form prior to initiation of study procedures

13
Investigator’s Responsibilities…cont’d

 Records & Reports


 Accuracy, completeness, legibility & timelines of the data
reported in CRF

 Progress Reports
 Written summaries of status of the trial to IRB/IEC
annually or as required by IRB/IEC
 Safety Reporting
 All SAEs should be reported to sponsor immediately
 AE or lab abnormalities identified as critical in protocol
should be notified to sponsor.

14
Investigator’s Responsibilities…cont’d

 Premature Termination or Suspension of Trial


 Inform subjects, ensure appropriate therapy & follow up of
the subjects

 If investigator or sponsor terminates/suspends trial – inform


institution & IRB/IEC

 Final Reports
 Provide summary of trial outcome to institution and IRB/IEC

15
CRA / Monitor

Who is CRA?
 Acts as main line of communication between sponsor and

the investigator.

 Visit & work with sites on behalf of sponsor

 Performs variety of clinical operations & monitoring

activities

 Often called as ‘Clinical Monitor’ or ‘Study Monitor’

16
CRA’s Responsibilities

Feasibility of trial Recruiting Investigators

Not acceptable Pre-Study Visits

Acceptable Site Initiation Visits

Routine Monitoring Visits

Site Close Out Visits

17
CRA’s Responsibilities…cont’d

 Evaluating & Selecting the investigators


 The Monitor is responsible for selecting the
investigator/institution. Each investigator should be
qualified by
 training
 experience and should have
 adequate resources
to properly conduct the trial for which the investigator is
selected

18
CRA’s Responsibilities…cont’d

 Pre Study Visit (site selection visit)

 Conducted at a potential research site

 Assess the investigator’s experience, staff, facility and

potential patient population

 Introduce the study & obligations to the potential

investigator & staff

19
CRA’s Responsibilities…cont’d

 Site Initiation Visit


 Conducted at a confirmed research site

 Verify the confirmed investigator’s experience, staff,

facility and potential patient population

 Detail the study & obligations to the potential

investigator & staff

 Collect all essential documents before this visit

20
CRA’s Responsibilities…cont’d

 Routine Monitoring Visit


 CRA’s main activity – study monitoring

 Purpose of monitoring:

 rights & well being of subjects are protected

 reported data are accurate, complete & verifiable

from source documents

 trial conduct is in compliance with protocol, GCP &

applicable regulatory requirements

21
CRA’s Responsibilities…cont’d

 Routine Monitoring Visit


 Review IP handling, storage conditions, receipt, use,
return and disposition

 Review all informed consent forms

 Review protocol compliance

 Review CRFs, source documents, site file

 Review AEs/SAEs

 Review facilities, resources, staffing

 Address questions and/or concerns

22
CRA’s Responsibilities…cont’d

 Site Close out Visit


 Site close out visit is conducted when

 Study is complete & finished

 Enrollment has stopped

 All subjects have completed their study related


activities

 Data are complete & correct

 Final IP accountability is done

23
CRA’s Responsibilities…cont’d

 Site Close out Visit


 Site close out visit is conducted to

 Retrieve all appropriate study supplies

 Verify that study documentation is complete &

accurate

 Ensure that site is in compliance with regulatory &

GCP guidelines

24
Thank you

25

You might also like